Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Robertson

Showing results (141-150 of 200) with videos related to

Pageof 20
Sort By:
Oncology|January 1, 1997
A randomised comparison of oestrogen suppression with anastrozole and formestane in postmenopausal patients with advanced breast cancerU R Kleeberg, M Dowsett, R P Carrion, et al.
British Journal of Cancer|June 1, 1992
Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growthS A Watson, D M Crosbee, D L Morris, et al.
The American Journal of Cardiology|August 1, 1981
Anatomic and electrophysiologic correlates of ventricular tachycardia requiring left ventricular stimulationJ F Robertson, M E Cain, L N Horowitz, et al.
International Journal of Cancer|June 17, 1999
BRCA1 expression levels predict distant metastasis of sporadic breast cancersL T Seery, J M Knowlden, J M Gee, et al.
Human Pathology|November 1, 1995
Assessment of angiogenesis in breast carcinoma: an important factor in prognosis?H Goulding, N F Abdul Rashid, J F Robertson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Safe selection criteria for breast conservation without radical excision in primary operable invasive breast cancerD M Sibbering, M H Galea, D A Morgan, et al.
International Journal of Cancer|February 13, 1999
Endocrine response and resistance in breast cancer: a role for the transcription factor FosJ M Gee, P C Willsher, F S Kenny, et al.
British Journal of Cancer|November 1, 1995
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapyS G Archer, A Eliopoulos, D Spandidos, et al.
The Journal of Pathology|November 1, 1991
Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11M H Galea, E Athanassiou, J Bell, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Short-term effects of pure anti-oestrogen ICI 182780 treatment on oestrogen receptor, epidermal growth factor receptor and transforming growth factor-alpha protein expression in human breast cancerR A McClelland, J M Gee, A B Francis, et al.
Pageof 20

Showing results (141-150 of 200) with videos related to

Sort By:
Pageof 20
Oncology|January 1, 1997
A randomised comparison of oestrogen suppression with anastrozole and formestane in postmenopausal patients with advanced breast cancerU R Kleeberg, M Dowsett, R P Carrion, et al.
British Journal of Cancer|June 1, 1992
Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growthS A Watson, D M Crosbee, D L Morris, et al.
The American Journal of Cardiology|August 1, 1981
Anatomic and electrophysiologic correlates of ventricular tachycardia requiring left ventricular stimulationJ F Robertson, M E Cain, L N Horowitz, et al.
International Journal of Cancer|June 17, 1999
BRCA1 expression levels predict distant metastasis of sporadic breast cancersL T Seery, J M Knowlden, J M Gee, et al.
Human Pathology|November 1, 1995
Assessment of angiogenesis in breast carcinoma: an important factor in prognosis?H Goulding, N F Abdul Rashid, J F Robertson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Safe selection criteria for breast conservation without radical excision in primary operable invasive breast cancerD M Sibbering, M H Galea, D A Morgan, et al.
International Journal of Cancer|February 13, 1999
Endocrine response and resistance in breast cancer: a role for the transcription factor FosJ M Gee, P C Willsher, F S Kenny, et al.
British Journal of Cancer|November 1, 1995
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapyS G Archer, A Eliopoulos, D Spandidos, et al.
The Journal of Pathology|November 1, 1991
Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11M H Galea, E Athanassiou, J Bell, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
Short-term effects of pure anti-oestrogen ICI 182780 treatment on oestrogen receptor, epidermal growth factor receptor and transforming growth factor-alpha protein expression in human breast cancerR A McClelland, J M Gee, A B Francis, et al.
Pageof 20